The Pharmaceutical Wholesale and Distribution Industry has survived on continual low profits while the pharmaceutical companies of whom its serves continues to thrive. The major problem facing the industry today is how to increase its profitability. The visiongain report 'The Pharmaceutical Wholesale and Distribution Industry, 2005' examines the current position of the industry and analyses in detail the following major issues:

• Fee-for-service and its viability
• Parallel trade and its future
• The Canada/US importation of drugs and how this will develop over time
• Drug counterfeiting
• The internet: mail order drugs and on-line pharmacies
• The Big Three US Wholesalers: AmerisourceBergen, McKesson and Cardinal Health

With over 30 tables, news, insights, the latest developments and a complete survey of the industry 'The Pharmaceutical Wholesale and Distribution Industry, 2005' is a vital addition in the understanding of this complex and involved industry.

• The increase in US online drug purchases ($bn), 2003-2010
• The drawbacks of fee-for-service
• Why parallel trade will not disappear
• How the drug companies are responding to the problem of Canada/US drug reimportation
• The methods to reduce but not prevent drug counterfeits from entering the drug supply chain